VUSAC Finance Chair resigns

On December 2nd, VUSAC Finance Chair Nicole* resigned from their position. Co-Presidents Rahul Christofferson and Stuart Norton considered the termination of Nicole due to the neglect of fiduciary responsibilities.  Nicole posted a Facebook status catalyzing the recent discussion around mental health and trans representation around campus. A post by VUSAC that stated the reasoning behind…

Revolutionary Gene-editing Technique Has Its First Clinical Anti-Cancer Tests in Humans

As the world grows more complex, we see hopeful signs of progress in the field of gene-based medicinal therapy. In particular, the famous CRISPR-Cas9 gene-editing technique has been gaining significant traction due to its simplicity and versatility. On October 28th, Dr. Lu You’s team at Sichuan University in Chengdu successfully implanted cells containing CRISPR-edited genes into a patient with lung cancer. While this may seem like a small step, it is a result with heavy implications for the future of biomedical research. Carl June, an immunotherapy specialist at the University of Pennsylvania, described the implications of this progress best, calling the possibility for an ensuing international duel in biomedical research “Sputnik 2.0.”